Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications

Abstract Background Hepatocellular carcinoma (HCC) remains a global health burden, with disproportionately high mortality in China’s Guangxi region, where endemic Clonorchis sinensis (C. sinensis) infection coincides with elevated HCC incidence. Preliminary single-cell sequencing revealed marked ove...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen-Min Lu, Jin Yan, Zhao-Ji Liu, Yong Wu, Qian-Ru Cui, Ji Feng, Yu Chen, Guang-Zhi Zhu, Tao Peng, Jing Zhou, Guo-Dong Lu
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Parasites & Vectors
Subjects:
Online Access:https://doi.org/10.1186/s13071-025-06979-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226548913111040
author Wen-Min Lu
Jin Yan
Zhao-Ji Liu
Yong Wu
Qian-Ru Cui
Ji Feng
Yu Chen
Guang-Zhi Zhu
Tao Peng
Jing Zhou
Guo-Dong Lu
author_facet Wen-Min Lu
Jin Yan
Zhao-Ji Liu
Yong Wu
Qian-Ru Cui
Ji Feng
Yu Chen
Guang-Zhi Zhu
Tao Peng
Jing Zhou
Guo-Dong Lu
author_sort Wen-Min Lu
collection DOAJ
description Abstract Background Hepatocellular carcinoma (HCC) remains a global health burden, with disproportionately high mortality in China’s Guangxi region, where endemic Clonorchis sinensis (C. sinensis) infection coincides with elevated HCC incidence. Preliminary single-cell sequencing revealed marked overexpression of cluster of differentiation 24 (CD24) in HCC tissues, suggesting its potential pathological role. This study aims to elucidate the oncogenic mechanisms of C. sinensis excretory-secretory products (CsESPs) and their link to CD24-mediated HCC progression. Methods We employed an integrated clinical and experimental approach. First, clinical cohort analysis assessed CD24 expression in C. sinensis-associated HCC cases. Multiplatform bioinformatics validation (GEPIA/UALCAN/TIMER) evaluated CD24’s prognostic significance and immune microenvironment modulation. Functional studies (quantitative polymerase chain reaction (qPCR), Western blotting, CCK-8 assays, flow cytometry) examined CsESPs’ effects on CD24 expression, cell proliferation, and apoptosis. Mechanistic investigations (chromatin immunoprecipitation, dual-luciferase reporter assays) identified E2F1-mediated transcriptional activation of CD24. siRNA-mediated CD24 knockdown validated its role in CsESPs-driven oncogenesis. Additionally, the expression of immune checkpoint (CTLA-4, LAG-3) was assessed in the co-cultures of peripheral blood mononuclear cells (PBMCs)–HCC cells. Results Clinical cohort analysis confirmed significant CD24 upregulation in HCC, particularly in C. sinensis-infected cases. Bioinformatic analyses linked high CD24 expression to poor prognosis and immune microenvironment alterations. Functional assays demonstrated that CsESPs enhance CD24 expression, promoting proliferation and inhibiting apoptosis. Mechanistically, E2F1 directly binds to CD24 promoter, driving its transcription upon CsESPs exposure. CD24 silencing reversed CsESPs-induced oncogenic effects. Furthermore, CsESPs upregulated immune checkpoints (CTLA-4, LAG-3) in the co-cultures of PBMC–HCC cells, an effect reversed by CD24 knockdown. Conclusions Our findings establish a novel parasitic carcinogenesis paradigm wherein C. sinensis promotes HCC development through E2F1-mediated transcriptional activation of CD24, simultaneously identifying prognostic biomarkers and therapeutic targets while suggesting combinatory immunotherapy strategies for parasite-associated HCC. Graphical Abstract
format Article
id doaj-art-0fe1d38f9c8b4ba2a80932c2b08397f0
institution Kabale University
issn 1756-3305
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj-art-0fe1d38f9c8b4ba2a80932c2b08397f02025-08-24T11:10:31ZengBMCParasites & Vectors1756-33052025-08-0118111810.1186/s13071-025-06979-6Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implicationsWen-Min Lu0Jin Yan1Zhao-Ji Liu2Yong Wu3Qian-Ru Cui4Ji Feng5Yu Chen6Guang-Zhi Zhu7Tao Peng8Jing Zhou9Guo-Dong Lu10Department of Toxicology, School of Public Health, Guangxi Medical UniversityDepartment of Physiology, School of Basic Medical Sciences, Guangxi Medical UniversityDepartment of Physiology, School of Basic Medical Sciences, Guangxi Medical UniversityDepartment of Toxicology, School of Public Health, Guangxi Medical UniversityDepartment of Physiology, School of Basic Medical Sciences, Guangxi Medical UniversitySchool of Public Health, Fudan UniversityHengzhou Center for Disease Control and PreventionDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Physiology, School of Basic Medical Sciences, Guangxi Medical UniversityDepartment of Toxicology, School of Public Health, Guangxi Medical UniversityAbstract Background Hepatocellular carcinoma (HCC) remains a global health burden, with disproportionately high mortality in China’s Guangxi region, where endemic Clonorchis sinensis (C. sinensis) infection coincides with elevated HCC incidence. Preliminary single-cell sequencing revealed marked overexpression of cluster of differentiation 24 (CD24) in HCC tissues, suggesting its potential pathological role. This study aims to elucidate the oncogenic mechanisms of C. sinensis excretory-secretory products (CsESPs) and their link to CD24-mediated HCC progression. Methods We employed an integrated clinical and experimental approach. First, clinical cohort analysis assessed CD24 expression in C. sinensis-associated HCC cases. Multiplatform bioinformatics validation (GEPIA/UALCAN/TIMER) evaluated CD24’s prognostic significance and immune microenvironment modulation. Functional studies (quantitative polymerase chain reaction (qPCR), Western blotting, CCK-8 assays, flow cytometry) examined CsESPs’ effects on CD24 expression, cell proliferation, and apoptosis. Mechanistic investigations (chromatin immunoprecipitation, dual-luciferase reporter assays) identified E2F1-mediated transcriptional activation of CD24. siRNA-mediated CD24 knockdown validated its role in CsESPs-driven oncogenesis. Additionally, the expression of immune checkpoint (CTLA-4, LAG-3) was assessed in the co-cultures of peripheral blood mononuclear cells (PBMCs)–HCC cells. Results Clinical cohort analysis confirmed significant CD24 upregulation in HCC, particularly in C. sinensis-infected cases. Bioinformatic analyses linked high CD24 expression to poor prognosis and immune microenvironment alterations. Functional assays demonstrated that CsESPs enhance CD24 expression, promoting proliferation and inhibiting apoptosis. Mechanistically, E2F1 directly binds to CD24 promoter, driving its transcription upon CsESPs exposure. CD24 silencing reversed CsESPs-induced oncogenic effects. Furthermore, CsESPs upregulated immune checkpoints (CTLA-4, LAG-3) in the co-cultures of PBMC–HCC cells, an effect reversed by CD24 knockdown. Conclusions Our findings establish a novel parasitic carcinogenesis paradigm wherein C. sinensis promotes HCC development through E2F1-mediated transcriptional activation of CD24, simultaneously identifying prognostic biomarkers and therapeutic targets while suggesting combinatory immunotherapy strategies for parasite-associated HCC. Graphical Abstracthttps://doi.org/10.1186/s13071-025-06979-6Hepatocellular carcinomaClonorchis sinensisCD24E2F1Tumor promotion
spellingShingle Wen-Min Lu
Jin Yan
Zhao-Ji Liu
Yong Wu
Qian-Ru Cui
Ji Feng
Yu Chen
Guang-Zhi Zhu
Tao Peng
Jing Zhou
Guo-Dong Lu
Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
Parasites & Vectors
Hepatocellular carcinoma
Clonorchis sinensis
CD24
E2F1
Tumor promotion
title Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
title_full Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
title_fullStr Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
title_full_unstemmed Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
title_short Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
title_sort clonorchis sinensis driven hepatocarcinogenesis via e2f1 cd24 transcriptional axis mechanistic and therapeutic implications
topic Hepatocellular carcinoma
Clonorchis sinensis
CD24
E2F1
Tumor promotion
url https://doi.org/10.1186/s13071-025-06979-6
work_keys_str_mv AT wenminlu clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT jinyan clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT zhaojiliu clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT yongwu clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT qianrucui clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT jifeng clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT yuchen clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT guangzhizhu clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT taopeng clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT jingzhou clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications
AT guodonglu clonorchissinensisdrivenhepatocarcinogenesisviae2f1cd24transcriptionalaxismechanisticandtherapeuticimplications